MBOT · Forms 3, 4, 5
Insider trades at Microbot Medical Inc.
No open-market insider buys or sells at Microbot Medical Inc. in the last 90 days; 10 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for Microbot Medical Inc. (MBOT) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Most recent insider filings
No Form 3, 4 or 5 filings for Microbot Medical Inc. in the last 90 days. The latest ones on EDGAR:
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Aileen Ptucha Stockburger | Director | Options or other derivatives | Form 4 | ||||
| Martin J. Madden | Director | Options or other derivatives | Form 4 | ||||
| Tal Baruch Wenderow | Director | Options or other derivatives | Form 4 | ||||
| David James Wilson | Director | Options or other derivatives | Form 4 | ||||
| Scott R Burell | Director | Options or other derivatives | Form 4 | ||||
| Prattipati Laxminarain | Director | Options or other derivatives | Form 4 | ||||
| Harel Gadot | Chairman, President and CEO | Options or other derivatives | Form 4 | ||||
| Juan Diaz-Cartelle | Chief Medical Officer | Options or other derivatives | Form 4 | ||||
| Simon Sharon | General Manager, CTO | Options or other derivatives | Form 4 | ||||
| Rachel Vaknin | Chief Financial Officer | Options or other derivatives | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.